Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05583045
Other study ID # 83/2022
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date November 1, 2022
Est. completion date July 2023

Study information

Verified date October 2022
Source Instituto Politécnico de Bragança
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this interventional study is investigating the effect of the daily consumption of olive leaves tea on glycemic control of individuals diagnosed with pre-diabetes. The hypothesis of this study is that the integration of olive leaf tea on daily food consumption will favors glycemic control and ameliorate insulin resistance in individuals with pre-diabetes.


Description:

This study is a triple-blinded, randomized, placebo-controlled trial with parallel assignment


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 140
Est. completion date July 2023
Est. primary completion date March 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: At least one of three glycemic criteria for pre diabetes as defined by 2022 American Diabetes Association (ADA) guidelines: - Fasting plasma glucose level, 100 to 125 mg per deciliter (5.6 to 6.9 mml per liter); - Plasma glucose level 2 hours after a 75-g oral glucose load, 140 to 199 mg per deciliter (7.8 to 11.0 mml per liter); - Glycated hemoglobin level, 5.7 to 6.4% (39 to 47 mml per mole). Exclusion Criteria: - Current use of medication for lowering blood cholesterol, glucose or hypertension; - History of chronic or severe diseases that may affect study outcomes or limit study participation; - Pregnancy and breastfeeding

Study Design


Intervention

Other:
Olive Leaf Tea
Olive leaf tea (individual tea bags provided to participants with instructions of preparation)
Behavioral:
Lifestyle behavior change program (LBC)
Lifestyle behavior change program as defined by America Diabetes Association on "Standards of Medical Care in Diabetes-2022 Abridged for Primary Care Providers"(Association 2022)
Other:
Placebo tea
Placebo tea containing 2,6g cellulose and a caramel coloring

Locations

Country Name City State
Portugal Instituto Politécnico de Bragança Bragança

Sponsors (3)

Lead Sponsor Collaborator
Instituto Politécnico de Bragança European Social Fund, Unidade Local de Saúde do Nordeste

Country where clinical trial is conducted

Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Primary HbA1c Effect of olive leaf tea (OLT) on HbA1c after 12 weeks of intervention in individuals with prediabetes 12 weeks
Secondary Fasting Plasma Glicose Effect of olive leaf tea (OLT) on FPG after 12 weeks of intervention in individuals with prediabetes 12 weeks
Secondary Insulin Effect of olive leaf tea (OLT) on Insulin after 12 weeks of intervention in individuals with prediabetes 12 weeks
Secondary Cholesterol Total, c-HDL, c-LDL and triglycerides Effect of olive leaf tea (OLT) on CT, c-HDL, c-LDL and TG after 12 weeks of intervention in individuals with prediabetes 12 weeks
Secondary Aspartate transaminase (AST) and Alanine transaminase (ALT) Effect of olive leaf tea (OLT) on AST and ALT after 12 weeks of intervention in individuals with prediabetes 12 weeks
Secondary Alkaline Phosphatase Effect of olive leaf tea (OLT) on Alkaline Phosphatase after 12 weeks of intervention in individuals with prediabetes 12 weeks
Secondary Bilirubin Effect of olive leaf tea (OLT) on Bilirubin after 12 weeks of intervention in individuals with prediabetes 12 weeks
Secondary Creatinine Effect of olive leaf tea (OLT) on Creatinine after 12 weeks of intervention in individuals with prediabetes 12 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2